Lipoprotein Metabolism in Diabetic Dyslipidemia

Lipoprotein metabolism is frequently disrupted in diabetic patients, leading to dyslipidemia—a key risk factor for cardiovascular disease. In diabetes, insulin resistance impairs the normal processing of lipoproteins, leading to elevated levels of triglycerides, reduced high-density lipoprotein (HDL) cholesterol, and an increase in small, dense low-density lipoprotein (LDL) particles. These lipid abnormalities contribute to the development of atherosclerosis, increasing the risk of heart disease and stroke. Managing diabetic dyslipidemia involves lifestyle modifications, glycemic control, and, in some cases, medications like statins to reduce cardiovascular risks associated with altered lipoprotein metabolism.